Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The "Get Fit for Function" clinical trial is focusing on helping adults who are considered pre-frail or frail and are scheduled to have thoracic surgery, which is surgery involving the chest area, often for lung issues. This study aims to test a program designed to prepare these patients physically before their surgery, potentially leading to better recovery outcomes. The researchers believe that using a specific approach will help more people access and benefit from this prehabilitation program.
To be eligible for the trial, participants must be at least 18 years old and planning to undergo elective thoracic surgery, such as lung resection. It's important that they can complete some initial assessments when they join the study. Participants can expect to take part in this prehab program, which may include exercises and health advice to improve their strength and fitness before surgery. The trial is currently recruiting volunteers of all genders, so if you or someone you know is interested and meets the criteria, this could be a valuable opportunity for better surgical outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18, of any racial or ethnic origin
- • Will be undergoing elective thoracic surgery lung resection using thoracic approach (thoracotomy, Video-assisted thoracoscopic surgery (VATS), Robotic-Assisted Thoracic Surgery (RATS)
- • Able to complete baseline evaluations at time of enrollment
- Exclusion Criteria:
- • Unable to give informed consent
- • Unable to read/speak English
- • Age \<17
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Maria Madariaga, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported